These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

223 related articles for article (PubMed ID: 21847014)

  • 21. Aβ-induced acceleration of Alzheimer-related τ-pathology spreading and its association with prion protein.
    Gomes LA; Hipp SA; Rijal Upadhaya A; Balakrishnan K; Ospitalieri S; Koper MJ; Largo-Barrientos P; Uytterhoeven V; Reichwald J; Rabe S; Vandenberghe R; von Arnim CAF; Tousseyn T; Feederle R; Giudici C; Willem M; Staufenbiel M; Thal DR
    Acta Neuropathol; 2019 Dec; 138(6):913-941. PubMed ID: 31414210
    [TBL] [Abstract][Full Text] [Related]  

  • 22. PrP(C) signalling in neurons: from basics to clinical challenges.
    Hirsch TZ; Hernandez-Rapp J; Martin-Lannerée S; Launay JM; Mouillet-Richard S
    Biochimie; 2014 Sep; 104():2-11. PubMed ID: 24952348
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Dissociation of infectivity from seeding ability in prions with alternate docking mechanism.
    Miller MB; Geoghegan JC; Supattapone S
    PLoS Pathog; 2011 Jul; 7(7):e1002128. PubMed ID: 21779169
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Systematic and standardized comparison of reported amyloid-β receptors for sufficiency, affinity, and Alzheimer's disease relevance.
    Smith LM; Kostylev MA; Lee S; Strittmatter SM
    J Biol Chem; 2019 Apr; 294(15):6042-6053. PubMed ID: 30787106
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Alzheimer amyloid-β oligomer bound to postsynaptic prion protein activates Fyn to impair neurons.
    Um JW; Nygaard HB; Heiss JK; Kostylev MA; Stagi M; Vortmeyer A; Wisniewski T; Gunther EC; Strittmatter SM
    Nat Neurosci; 2012 Sep; 15(9):1227-35. PubMed ID: 22820466
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Correlation of polydispersed prion protein and characteristic pathology in the thalamus in variant Creutzfeldt-Jakob disease: implication of small oligomeric species.
    Choi YP; Gröner A; Ironside JW; Head MW
    Brain Pathol; 2011 May; 21(3):298-307. PubMed ID: 21029243
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Mechanisms of prion transmission].
    Sakaguchi S
    Nihon Rinsho; 2007 Aug; 65(8):1391-5. PubMed ID: 17695274
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Identification of a Compound That Disrupts Binding of Amyloid-β to the Prion Protein Using a Novel Fluorescence-based Assay.
    Risse E; Nicoll AJ; Taylor WA; Wright D; Badoni M; Yang X; Farrow MA; Collinge J
    J Biol Chem; 2015 Jul; 290(27):17020-8. PubMed ID: 25995455
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Novel amplification mechanism of prions through disrupting sortilin-mediated trafficking.
    Sakaguchi S; Uchiyama K
    Prion; 2017 Nov; 11(6):398-404. PubMed ID: 29099278
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Sonication induced intermediate in prion protein conversion.
    Zukas AA; Bruederle CE; Carter JM
    Protein Pept Lett; 2008; 15(2):206-11. PubMed ID: 18289112
    [TBL] [Abstract][Full Text] [Related]  

  • 31. High molecular mass assemblies of amyloid-β oligomers bind prion protein in patients with Alzheimer's disease.
    Dohler F; Sepulveda-Falla D; Krasemann S; Altmeppen H; Schlüter H; Hildebrand D; Zerr I; Matschke J; Glatzel M
    Brain; 2014 Mar; 137(Pt 3):873-86. PubMed ID: 24519981
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Residue-specific mobility changes in soluble oligomers of the prion protein define regions involved in aggregation.
    Glaves JP; Ladner-Keay CL; Bjorndahl TC; Wishart DS; Sykes BD
    Biochim Biophys Acta Proteins Proteom; 2018 Sep; 1866(9):982-988. PubMed ID: 29935976
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Exosomal cellular prion protein drives fibrillization of amyloid beta and counteracts amyloid beta-mediated neurotoxicity.
    Falker C; Hartmann A; Guett I; Dohler F; Altmeppen H; Betzel C; Schubert R; Thurm D; Wegwitz F; Joshi P; Verderio C; Krasemann S; Glatzel M
    J Neurochem; 2016 Apr; 137(1):88-100. PubMed ID: 26710111
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A new method for the characterization of strain-specific conformational stability of protease-sensitive and protease-resistant PrPSc.
    Pirisinu L; Di Bari M; Marcon S; Vaccari G; D'Agostino C; Fazzi P; Esposito E; Galeno R; Langeveld J; Agrimi U; Nonno R
    PLoS One; 2010 Sep; 5(9):e12723. PubMed ID: 20856860
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Pressure-assisted dissociation and degradation of "proteinase K-resistant" fibrils prepared by seeding with scrapie-infected hamster prion protein.
    Akasaka K; Maeno A; Murayama T; Tachibana H; Fujita Y; Yamanaka H; Nishida N; Atarashi R
    Prion; 2014; 8(4):314-8. PubMed ID: 25482603
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The cellular prion protein mediates neurotoxic signalling of β-sheet-rich conformers independent of prion replication.
    Resenberger UK; Harmeier A; Woerner AC; Goodman JL; Müller V; Krishnan R; Vabulas RM; Kretzschmar HA; Lindquist S; Hartl FU; Multhaup G; Winklhofer KF; Tatzelt J
    EMBO J; 2011 May; 30(10):2057-70. PubMed ID: 21441896
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Prion protein self-peptides modulate prion interactions and conversion.
    Rigter A; Priem J; Timmers-Parohi D; Langeveld JP; van Zijderveld FG; Bossers A
    BMC Biochem; 2009 Nov; 10():29. PubMed ID: 19943977
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Distribution of the cellular prion protein (PrPC) in brains of livestock and domesticated species.
    Díaz-San Segundo F; Salguero FJ; de Avila A; Espinosa JC; Torres JM; Brun A
    Acta Neuropathol; 2006 Nov; 112(5):587-95. PubMed ID: 16957924
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Memory impairment in transgenic Alzheimer mice requires cellular prion protein.
    Gimbel DA; Nygaard HB; Coffey EE; Gunther EC; Laurén J; Gimbel ZA; Strittmatter SM
    J Neurosci; 2010 May; 30(18):6367-74. PubMed ID: 20445063
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Green tea extracts interfere with the stress-protective activity of PrP and the formation of PrP.
    Rambold AS; Miesbauer M; Olschewski D; Seidel R; Riemer C; Smale L; Brumm L; Levy M; Gazit E; Oesterhelt D; Baier M; Becker CF; Engelhard M; Winklhofer KF; Tatzelt J
    J Neurochem; 2008 Oct; 107(1):218-29. PubMed ID: 18691383
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.